Posts

Showing posts with the label pharmaceutical industry

Irritable Bowel Syndrome is caused by virus or Bacteria present in the Intestines

Image
Irritable bowel syndrome is a digestive system illness that causes stomach pain and changes in bowel habits. It obstructs the normal mobility of intestinal muscular linings, which is necessary for food to flow through the digestive tract. Irritable bowel syndrome is classified as mild, moderate, or severe depending on the symptoms. Cramps, abdominal pain, bloating and gas, mucus in the stool, constipation, and diarrhoea are some of the symptoms. Irritable bowel syndrome has no established aetiology, however it has been linked to increased awareness of body functions and irregular gastrointestinal tract motions. The global Irritable Bowel Syndrome Treatment Market was valued at US$ 726.1 million in 2016 and is expected to witness a robust CAGR of 12.9% over the forecast period (2017-2025). Tests such as blood tests, stool tests, endoscopic procedures, and external imaging procedures are used to diagnose irritable bowel syndrome. Irritable bowel syndrome patients may develop consequen...

Cancer and other pain-related disorders are becoming more common, Hence Improving drives for Meperidine (Demerol) Market

Image
  Meperidine is a pain reliever that is used to treat moderate to severe pain. It can be used both before and after surgery or other operations. Meperidine is comparable to morphine and belongs to the opioid analgesics class of medicines. It alters the way your body perceives and responds to pain by acting on the brain. Long-term or persistent pain should not be treated with meperidine. It should only be used to treat moderate to severe pain that occurs suddenly. Also see the section on Precautions. Because of the increased risk of major adverse effects, this medicine is not advised for use in infants. For more information, consult your doctor or pharmacist. The global Meperidine (Demerol) market is estimated to be valued at US$ 480.4 million in 2021 and is expected to exhibit a CAGR of 1.5% during the forecast period (2021-2028). As instructed by your doctor, this drug is injected into a vein, muscle, or beneath the skin. If you're providing this medication to yourself at home,...